Koji Hasegawa
Overview
Explore the profile of Koji Hasegawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
330
Citations
4690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wong J, Wang L, Hasegawa K, Ho K, Huang Z, Teo L, et al.
Eur Heart J Open
. 2024 Apr;
4(2):oeae025.
PMID: 38659665
Aims: Aging-related cardiovascular disease and frailty burdens are anticipated to rise with global aging. In response to directions from major cardiovascular societies, we investigated frailty knowledge, awareness, and practices among...
12.
Yamakage H, Jo T, Tanaka M, Kato S, Hasegawa K, Masuda I, et al.
Front Endocrinol (Lausanne)
. 2024 Apr;
15:1343153.
PMID: 38601201
Objective: This study aimed to identify the amount of weight loss needed in patients with obesity to improve metabolic syndrome (MetS), a risk factor for cardiovascular disease (CVD), over a...
13.
Xu S, Shiomi H, Yamashita Y, Koyama S, Horie T, Baba O, et al.
PLoS One
. 2024 Mar;
19(3):e0297231.
PMID: 38507394
Familial hypercholesterolemia is an inherited disorder that remains underdiagnosed. Conventional genetic testing methods such as next-generation sequencing (NGS) or target PCR are based on the amplification process. Due to the...
14.
Katanasaka Y, Yabe H, Murata N, Sobukawa M, Sugiyama Y, Sato H, et al.
Nat Commun
. 2024 Mar;
15(1):2472.
PMID: 38503742
Protein arginine methyltransferase 5 (PRMT5) is a well-known epigenetic regulatory enzyme. However, the role of PRMT5-mediated arginine methylation in gene transcription related to cardiac fibrosis is unknown. Here we show...
15.
Hamatani Y, Iguchi M, Okamoto K, Nakanishi Y, Minami K, Ishigami K, et al.
Eur Heart J Open
. 2024 Mar;
4(2):oeae015.
PMID: 38487366
Aims: Atrial fibrillation (AF) increases the risk of heart failure (HF); however, little is known regarding the risk stratification for incident HF in AF patients, especially with preserved left ventricular...
16.
Sunagawa Y, Tsukabe R, Irokawa Y, Funamoto M, Suzuki Y, Yamada M, et al.
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397020
Anserine, an imidazole dipeptide, is present in the muscles of birds and fish and has various bioactivities, such as anti-inflammatory and anti-fatigue effects. However, the effect of anserine on the...
17.
Dorotheo E, Arora M, Banerjee A, Bianco E, Cheah N, Dalmau R, et al.
Glob Heart
. 2024 Feb;
19(1):14.
PMID: 38312998
Nicotine is universally recognized as the primary addictive substance fuelling the continued use of tobacco products, which are responsible for over 8 million deaths annually. In recent years, the popularity...
18.
Mittal S, Komiyama M, Ozaki Y, Yamakage H, Satoh-Asahara N, Wada H, et al.
Eur Heart J Open
. 2024 Jan;
4(1):oead135.
PMID: 38250139
Aims: Initiating smoking in early adolescence results in challenges with smoking cessation and is associated with high risk of cardiovascular disease. Recently, the initiation of smoking has transitioned from adolescence...
19.
Tsuji S, Otani C, Horie T, Watanabe S, Baba O, Sowa N, et al.
Biomed Pharmacother
. 2023 Dec;
170:115850.
PMID: 38091636
Aims: As heart failure (HF) progresses, ATP levels in myocardial cells decrease, and myocardial contractility also decreases. Inotropic drugs improve myocardial contractility but increase ATP consumption, leading to poor prognosis....
20.
Iguchi M, Tamargo J, Hasegawa K
Eur Heart J Cardiovasc Pharmacother
. 2023 Nov;
10(2):100-102.
PMID: 38031332
No abstract available.